MIT Bioengineer Advances Survival, Promise of Adult Stem Cells
MIT researchers have developed a technique to encourage the survival and growth of adult stem cells, a step that could help realize the therapeutic potential of such cells.
Major Discovery in Advancing of Regenerative Medicine
Scientists at Forsyth may have moved one step closer to regenerating human spinal cord tissue by artificially inducing a frog tadpole to re-grow its tail at a stage in its development when it is normally impossible. Using a variety of methods including a kind of gene therapy, the scientists altered the electrical properties of cells thus inducing regeneration.
Inter-Species Stem Cells to Be Created
A team of Korean scientists has come close to creating interspecies stem cells by combining monkey cells with cow ova for the first time in history.
Gene Required For Steps From Embryonic To Heart Muscle Cell
An important choreographer of the complicated dance of signals, enzymes and proteins that takes embryonic stem cells through the steps to becoming a beating heart muscle cell is the gene Sox17.
New Imaging Technique Tracks Traffic Patterns Of White Blood Cells
Researchers at Mount Sinai School of Medicine have just developed an advanced imaging technique to capture the movement of the microdomains of leukocytes or white blood cells.
Healtheuniverse Announces Non-Embryonic Adult Stem Cell Technology Approaching Clinical Trials
Healtheuniverse Inc. announced today that the Company’s non-embryonic stem cell technology is being prepared for clinical trials.
Liposuctioned Fat Stem Cells To Repair Bodies
A team led by Philippe Collas at the University of Oslo in Norway has identified certain chemical marks that allow him to predict which, among the hundreds of millions of stem cells in liposuctioned fat, are best at regenerating tissue.
Athersys, Inc. Completes GMP Manufacturing of Multistem(R) for Clinical Trials
Athersys, Inc. has announced that it has successfully produced a clinical grade master cell bank and initial product doses intended to support its clinical trial activity in 2007 and 2008.
TVAX Gets OK for Human Trial of Brain-cancer Therapy
TVAX Biomedical has received authorization from the Food and Drug Administration to begin a large-scale human trial to test a new immunotherapy for brain cancer.
Gene Therapy Shows Promise as Treatment for Diseased Limbs
New research led by an Ohio State University Medical Center vascular medicine specialist suggests that gene therapy is a safe treatment method to explore in patients whose lower limbs are at risk for amputation because of poor circulation caused by blocked blood vessels.
Dendreon Announces FDA’s Cellular, Tissue and Gene Therapies Advisory Committee to Review Provenge(R) for the Treatment of Asymptomatic, Metastatic, Androgen-Independent Prostate Cancer
Dendreon Corporation has announced that the U.S. Food and Drug Administration’s Office of Cellular, Tissue and Gene Therapies Advisory Committee will review the Biologics License Application (BLA) for PROVENGE (sipuleucel-T), the Company’s investigational active cellular immunotherapy (ACI) for the treatment of asymptomatic, metastatic, androgen-independent (also known as hormone refractory) prostate cancer on March 29, 2007.
Milestone In Finding Diabetes Cure: Pigs Arrive In Biosecure Facility
Spring Point Project, a non-profit organization created to expedite the widespread availability of islet tissue for diabetes care, has now conducted the first animal population of its biosecure animal facility in Western Wisconsin to breed and maintain high-health, pathogen-free pigs.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Concise Review: Stem Cells, Myocardial Regeneration, and Methodological Artifacts
This review discusses the current controversy about the role that endogenous and exogenous progenitor cells have in cardiac homeostasis and myocardial regeneration following injury.
A Pure Population of Lung Alveolar Epithelial Type II Cells Derived from Human Embryonic Stem Cells
The data presented in this study document the successful generation of a pure population of Alveolar epithelial type II (ATII) cells derived from hES cells, providing a practical source of ATII cells to explore in disease models their potential in the regeneration and repair of the injured alveolus and in the therapeutic treatment of genetic diseases affecting the lung.